LLY peer analysis
Eli Lilly (LLY) against its competitors: price, today's move, 1-year return and market value side by side.
LLY and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABBV AbbVie | $289.30 | -1.90% | 26.82% | $521.11B |
| AMGN Amgen | $464.82 | -0.26% | 58.91% | $251.94B |
| AZN AstraZeneca | $186.20 | -0.24% | 13.13% | $289.48B |
| JNJ Johnson & Johnson | $269.17 | -1.48% | 42.12% | $657.68B |
| MRK Merck | $148.52 | -0.67% | 72.14% | $368.89B |
| NVO Novo Nordisk | $40.66 | 1.65% | -18.86% | $176.43B |
| NVS Novartis | $160.84 | 0.03% | 31.10% | $303.67B |
| PFE Pfizer | $30.50 | -0.07% | 25.03% | $173.95B |
| SNY Sanofi | $45.23 | 2.01% | -11.20% | $106.24B |
| LLY Eli Lilly | $1,403.00 | -1.03% | 66.84% | $1.26T |
- LLY's peers: ABBV (AbbVie), AMGN (Amgen), AZN (AstraZeneca), JNJ (Johnson & Johnson), MRK (Merck), NVO (Novo Nordisk), NVS (Novartis), PFE (Pfizer).
Updated 2026-11-02 17:14 UTC